Related Experiment Videos
Relapse rates following leprosy multidrug therapy
1Hansen's Disease Control Unit, Ministry of Health, Port of Spain, Trinidad and Tobago.
The West Indian Medical Journal
|November 15, 2000
Summary
Leprosy patients in Trinidad and Tobago showed low relapse rates after multidrug therapy. Multibacillary cases had a 0.65% relapse rate, and paucibacillary cases had 1.5%.
Area of Science:
- Epidemiology
- Infectious Diseases
- Public Health
Background:
- Leprosy, a chronic infectious disease, requires effective treatment regimens.
- Multidrug therapy (MDT) is the standard treatment for all forms of leprosy.
- Monitoring treatment outcomes, including relapse rates, is crucial for disease control.
Purpose of the Study:
- To determine the relapse rates among leprosy patients treated with MDT in Trinidad and Tobago.
- To compare these relapse rates with established global benchmarks.
Main Methods:
- Retrospective study design.
- Analysis of patient records from January 1982 to December 1994.
- Categorization of patients into multibacillary and paucibacillary groups.
Main Results:
- Overall low relapse rates observed.
- Multibacillary leprosy cases exhibited a relapse rate of 0.65%.
- Paucibacillary leprosy cases exhibited a relapse rate of 1.5%.
Conclusions:
- MDT is effective in preventing relapses in leprosy patients in Trinidad and Tobago.
- Observed relapse rates are comparable to World Health Organization (WHO) estimates.
- Sustained vigilance and monitoring are essential for leprosy elimination efforts.